The IASLC 2022 World Conference on Lung Cancer congress held in Vienna, Austria gathered clinicians, researchers and scientists in the field of lung cancer and thoracic oncology from around the globe to discuss the latest exciting updates in lung cancer.
View all videos

WCLC 2022

IASLC 2022 World Congress on Lung Cancer
06–09 August 2022 | Vienna, Austria
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

Reply on Twitter 1642200195843735552Retweet on Twitter 1642200195843735552Like on Twitter 16422001958437355521Twitter 1642200195843735552
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

Reply on Twitter 1642177541820633095Retweet on Twitter 1642177541820633095Like on Twitter 16421775418206330953Twitter 1642177541820633095
Retweet on TwitterVJ Oncology Retweeted
montypalSumanta K. Pal, MD, FASCO@montypal·
March 31, 2023

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

Reply on Twitter 1641796231939899392Retweet on Twitter 164179623193989939216Like on Twitter 164179623193989939252Twitter 1641796231939899392
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

Reply on Twitter 1642086945680392192Retweet on Twitter 1642086945680392192Like on Twitter 16420869456803921924Twitter 1642086945680392192
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Reply on Twitter 1642044272596643842Retweet on Twitter 1642044272596643842Like on Twitter 16420442725966438425Twitter 1642044272596643842
Load More

WCLC 2022

IASLC 2022 World Congress on Lung Cancer
06–09 August 2022 | Vienna, Austria
The IASLC 2022 World Conference on Lung Cancer congress held in Vienna, Austria gathered clinicians, researchers and scientists in the field of lung cancer and thoracic oncology from around the globe to discuss the latest exciting updates in lung cancer.
View all videos
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

Reply on Twitter 1642200195843735552Retweet on Twitter 1642200195843735552Like on Twitter 16422001958437355521Twitter 1642200195843735552
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

Reply on Twitter 1642177541820633095Retweet on Twitter 1642177541820633095Like on Twitter 16421775418206330953Twitter 1642177541820633095
Retweet on TwitterVJ Oncology Retweeted
montypalSumanta K. Pal, MD, FASCO@montypal·
March 31, 2023

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

Reply on Twitter 1641796231939899392Retweet on Twitter 164179623193989939216Like on Twitter 164179623193989939252Twitter 1641796231939899392
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

Reply on Twitter 1642086945680392192Retweet on Twitter 1642086945680392192Like on Twitter 16420869456803921924Twitter 1642086945680392192
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Reply on Twitter 1642044272596643842Retweet on Twitter 1642044272596643842Like on Twitter 16420442725966438425Twitter 1642044272596643842
Load More

Latest videos from WCLC 2022

View all videos
1:07
NAUTIKA1: targeted therapies in biomarker-selected stage IB-II NSCLC
Jay M. Lee • 7 Aug 2022
2:00
Aurora A kinase inhibition with VIC-1911 potentiates KRASG12Ci and overcomes resistance
Jong Woo Lee • 7 Aug 2022
1:49
1L treatment in mesothelioma: optimizing treatments for individual patients
Wanda Cui • 7 Aug 2022
0:56
NAUTIKA1: safety and tolerability of neoadjuvant alectinib in ALK-positive NSCLC
Jay M. Lee • 7 Aug 2022

Clinical Trial Updates

View all videos
5:41
JAVELIN Lung100, PRIMUS, NintNivo, IMpower010: investigating IO in NSCLC
Martin Reck • 8 Aug 2022
0:26
Results of CeLEBrATE: carboplatin, etoposide, bevacizumab + atezolizumab ES-SCLC
Giuseppe Lamberti • 7 Aug 2022
0:56
NAUTIKA1: safety and tolerability of neoadjuvant alectinib in ALK-positive NSCLC
Jay M. Lee • 7 Aug 2022
1:06
METROS: crizotinib in ROS1+NSCLC long-term OS analysis in patients with brain metastasis
Federico Cappuzzo • 7 Aug 2022

Molecular Profiling

View all videos
0:41
Will ctDNA replace pathologic complete response in NSCLC?
Atocha Romero • 7 Aug 2022
1:22
The identification of actionable mutations in lung cancer via ctDNA
Wanda Cui • 7 Aug 2022
1:18
MRD status in lung cancer
Federico Cappuzzo • 7 Aug 2022
1:04
Molecular testing in EGFR mutant driven NSCLC
Julia Rotow • 7 Aug 2022
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals